CGP 6.78% 6.3¢ consegna group limited

options getting targeted now, page-28

  1. 10,778 Posts.
    Here is why

    "In June 2013, the Company announced compelling results from its elite athlete BreatheAssist nasal device user trial carried out in May 2013.
    Aside from information already publically announced. The Company is not aware of any explanation for the price and volume changes in the Company’s securities."
 
watchlist Created with Sketch. Add CGP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.